Your browser doesn't support javascript.
[Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients]. / Seguridad e inmunogenicidad de cilgavimab-tixagevimab para la profilaxis preexposición frente a la COVID-19 en pacientes inmunodeprimidos.
Fernández-Prada, María; Pérez-Martín, Jaime Jesús; Cienfuegos-González, Paula.
  • Fernández-Prada M; Servicio de Medicina Preventiva y Salud Pública, Hospital Vital Álvarez Buylla, Mieres, Asturias, España. Electronic address: mariafdezprada@gmail.com.
  • Pérez-Martín JJ; Subdirector General de Salud Pública, Consejería de Salud de la Región de Murcia, Murcia, España.
  • Cienfuegos-González P; Servicio de Medicina Preventiva y Salud Pública, Hospital Vital Álvarez Buylla, Mieres, Asturias, España.
Med Clin (Barc) ; 160(10): 458-459, 2023 05 26.
Article in English, Spanish | MEDLINE | ID: covidwho-2240671
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pre-Exposure Prophylaxis / COVID-19 Limits: Humans Language: English / Spanish Journal: Med Clin (Barc) Year: 2023 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pre-Exposure Prophylaxis / COVID-19 Limits: Humans Language: English / Spanish Journal: Med Clin (Barc) Year: 2023 Document Type: Article